Brad Willock Taro Pharmaceuticals Inds TARO-Q PAST TOP PICK Apr 19, 2002

(Was a top pick on Feb 22 down 20%) Still likes. Down because it is Israeli based.

Brad Willock

Unknown

Unlock Rating

$26.950

Stock price when the opinion was issued

biotechnology pharmaceutical

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

TOP PICK

Earnings are growing very fast, over 50%. Has new products comimg out. Small debt.

BUY ON WEAKNESS

Generic drugs is a great sector. Accumulate on a gradual basis.

Most Recent Experts

Greg Newman

Scotia Wealth Management

Stockchase Insights

5i Research

Shane Obata

Middlefield Capital

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Andrew Pyle

The Pyle Group, Scotia Wealth Mgt.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Brad Willock Taro Pharmaceuticals Inds TARO-Q PAST TOP PICK Apr 19, 2002

You might be interested:

Taro Pharmaceuticals Inds(TARO-Q)

Taro Pharmaceuticals Inds(TARO-Q)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals